Core Viewpoint - The company has signed a three-year natural uranium sales agreement with its parent company, China Uranium Development, for the years 2026-28, with benchmark prices and annual increment factors exceeding market expectations, indicating a positive outlook for the global nuclear energy revival and the company's profitability and valuation [1] Pricing and Sales Agreement - The benchmark price for the new agreement is set at 98.08, and 80 per pound since February [1] - The annual increment factor for the new agreement is increased to 4.1%, up from 3.5% in the previous agreement, reflecting a positive industry outlook on global uranium supply and demand tightening [2] - The proportion of spot price in the pricing formula has been raised from 60% to 70%, enhancing the company's profit elasticity and aligning future sales prices more closely with spot market trends [2] Sales Capacity and Growth Potential - The annual sales cap in the new agreement considers potential resource increases, with expected annual sales volumes of 1,438, 1,617, and 1,598 tons of U3O8 for the years 2026, 2027, and 2028, plus an additional buffer of 600 tons per year [2] - This clause reinforces the company's role as a platform for overseas uranium asset development under China General Nuclear Power Group, highlighting its growth potential in seeking uranium resource investment opportunities [2] Profit Forecast and Valuation - The company has adjusted its net profit forecasts for 2026-27 upwards by 15% and 10% to 1.028 billion and 1.135 billion yuan respectively, with corresponding EPS of 0.14 and 0.15 yuan [2] - The target price has been raised to HKD 2.43 from HKD 1.88, reflecting a clearer expectation of volume and price for 2026, with a P/E ratio of 18.0x for 2026 [2]
中广核矿业(1164.HK):新三年铀买卖协议量、价、率均超预期 行业BETA与公司ALPHA共振